Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125830697 | 12583069 | 7 | F | 20160110 | 20160912 | 20160722 | 20160920 | EXP | IT-PFIZER INC-2016347501 | PFIZER | 81.00 | YR | F | Y | 0.00000 | 20160920 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125830697 | 12583069 | 1 | PS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, DAILY | Y | 20987 | 40 | MG | TABLET | ||||||
| 125830697 | 12583069 | 2 | SS | Triatec | RAMIPRIL | 1 | Oral | 5 MG, DAILY | 6562 | MG | U | 19901 | 5 | MG | TABLET | ||||
| 125830697 | 12583069 | 3 | SS | TRIPLIAM | AMLODIPINEINDAPAMIDEPERINDOPRIL | 1 | Oral | 1 MG, DAILY 10 MG/2.5 MG/5 MG TABLET (PERINDOPRIL/ARGININE/INDAPAMIDE | 6562 | MG | Y | 0 | 1 | DF | FILM-COATED TABLET | ||||
| 125830697 | 12583069 | 4 | C | NORVASC | AMLODIPINE BESYLATE | 1 | UNK | 0 | TABLET | ||||||||||
| 125830697 | 12583069 | 5 | C | ASCRIPTIN | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 125830697 | 12583069 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | UNK | 0 | |||||||||||
| 125830697 | 12583069 | 7 | C | NORMIX | RIFAXIMIN | 1 | UNK | 0 | |||||||||||
| 125830697 | 12583069 | 8 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | UNK | 0 | |||||||||||
| 125830697 | 12583069 | 9 | C | LENTO-KALIUM | 2 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125830697 | 12583069 | 1 | Antacid therapy |
| 125830697 | 12583069 | 2 | Essential hypertension |
| 125830697 | 12583069 | 3 | Essential hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125830697 | 12583069 | HO |
| 125830697 | 12583069 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125830697 | 12583069 | Confusional state | |
| 125830697 | 12583069 | Diarrhoea | |
| 125830697 | 12583069 | Hypokalaemia | |
| 125830697 | 12583069 | Hyponatraemia | |
| 125830697 | 12583069 | Nausea | |
| 125830697 | 12583069 | Vomiting | |
| 125830697 | 12583069 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125830697 | 12583069 | 1 | 20150101 | 20160110 | 0 | |
| 125830697 | 12583069 | 2 | 20150101 | 20160110 | 0 | |
| 125830697 | 12583069 | 3 | 20150101 | 20160110 | 0 |